NEW FYN AND VEGFR2 KINASE INHIBITORS

The invention relates to a N-phenylcarbamoyl compound of Formula (I) or a pharmaceutically acceptable salt thereof for use in the inhibition of at least one of tyrosine kinase selected from Fyn and VEGFR2 in the treatment of diseases and disorders involved with one or both kinases. L'invention...

Full description

Saved in:
Bibliographic Details
Main Authors BOVINO, Clara, MAGARACI, Filippo, ROVATI, Lucio Claudio, COLACE, Fabrizio, MANDELLI, Stefano, MENNUNI, Laura, ARTUSI, Roberto, BUZZI, Benedetta, CASELLI, Gianfranco
Format Patent
LanguageEnglish
French
Published 14.07.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to a N-phenylcarbamoyl compound of Formula (I) or a pharmaceutically acceptable salt thereof for use in the inhibition of at least one of tyrosine kinase selected from Fyn and VEGFR2 in the treatment of diseases and disorders involved with one or both kinases. L'invention concerne un composé N-phénylcarbamoyle de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci, destiné à être utilisé dans l'inhibition d'au moins l'une des tyrosine kinases choisies parmi Fyn et VEGFR2 dans le traitement de maladies et de troubles dans lesquels l'une ou les deux kinases sont impliquées.
AbstractList The invention relates to a N-phenylcarbamoyl compound of Formula (I) or a pharmaceutically acceptable salt thereof for use in the inhibition of at least one of tyrosine kinase selected from Fyn and VEGFR2 in the treatment of diseases and disorders involved with one or both kinases. L'invention concerne un composé N-phénylcarbamoyle de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci, destiné à être utilisé dans l'inhibition d'au moins l'une des tyrosine kinases choisies parmi Fyn et VEGFR2 dans le traitement de maladies et de troubles dans lesquels l'une ou les deux kinases sont impliquées.
Author ROVATI, Lucio Claudio
MENNUNI, Laura
MANDELLI, Stefano
BOVINO, Clara
ARTUSI, Roberto
COLACE, Fabrizio
BUZZI, Benedetta
CASELLI, Gianfranco
MAGARACI, Filippo
Author_xml – fullname: BOVINO, Clara
– fullname: MAGARACI, Filippo
– fullname: ROVATI, Lucio Claudio
– fullname: COLACE, Fabrizio
– fullname: MANDELLI, Stefano
– fullname: MENNUNI, Laura
– fullname: ARTUSI, Roberto
– fullname: BUZZI, Benedetta
– fullname: CASELLI, Gianfranco
BookMark eNrjYmDJy89L5WRQ8XMNV3CL9FNw9HNRCHN1dwsyUvD29HMMdlXw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGhoaGZgYGpo4WxsSpAgDOpyVX
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate NOUVEAUX INHIBITEURS DE KINASE FYN ET VEGFR2
ExternalDocumentID WO2021116005A8
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2021116005A83
IEDL.DBID EVB
IngestDate Fri Jul 19 12:50:58 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2021116005A83
Notes Application Number: WO2020EP84847
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220714&DB=EPODOC&CC=WO&NR=2021116005A8
ParticipantIDs epo_espacenet_WO2021116005A8
PublicationCentury 2000
PublicationDate 20220714
PublicationDateYYYYMMDD 2022-07-14
PublicationDate_xml – month: 07
  year: 2022
  text: 20220714
  day: 14
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies ROTTAPHARM BIOTECH S.R.L
RelatedCompanies_xml – name: ROTTAPHARM BIOTECH S.R.L
Score 3.4041564
Snippet The invention relates to a N-phenylcarbamoyl compound of Formula (I) or a pharmaceutically acceptable salt thereof for use in the inhibition of at least one of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title NEW FYN AND VEGFR2 KINASE INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220714&DB=EPODOC&locale=&CC=WO&NR=2021116005A8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp-LHlIKjb8Ut_czDkH6ktoLt6Oo2n8bapiDIHK7iv--ldLqnvYUcXJKDu8vvcncB6KmDjFPVMBRa6KaiqSVVqEVMhSDaWqiivQivsy0iI3jVnmf6rAUfm1qYuk_oT90cETUqR32vanu9-g9ieXVu5fohe8epz0c_HXpyg44JEfU4sucM2Sj2Yld2XcRtcpQIGmo1enfdtvZgX1ykRad9NnFEXcpq26n4J3AwQn7L6hRafNmBI3fz91oHDl-aJ28cNtq3PoNexKaS_xZJduRJE_bkJ0RC9G2PmRRGQeiEaZyMz-HeZ6kbKLjc_O9082m8vTf1AtqI-_klSLlVkFIYsr6Za5xTqpdqvxCokpj6oNSvoLuL0_Vu8g0cC3mJMOVA60K7-vrmt-hfq-yuFssvd1R3sg
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTsWPqQVH34pr2q7Nw5CtH7a6pWOr-3gqrk1BkDlcxX_fS-l0T3sLObgkB3eX3-XuAtDU1AWnWrut0NQwFV3LqEItYioE0dabJtqL8CLbgrX9V_15Zswq8LGphSn6hP4UzRFRoxLU97yw16v_IJZT5FauHxbvOPX56EUdRy7RMSGiHkd2eh13GDqhLds24jaZjQQNtRq9u9G19mDfFP15xeVp0hN1Kattp-Idw8EQ-S3zE6jwZR1q9ubvtTocDsonbxyW2rc-hSZzp5I3Z1KXOdLEffJGREL03R27UsD8oBdE4Wh8BveeG9m-gsvFf6eLp-H23rRzqCLu5xcgJVZKMmHIWmaic06pkWmtVKBKYhpqZlxCYxenq93kO6j50aAf9wP2cg1HQnYiZKnqDajmX9_8Bn1tvrgtRPQLOEh6nw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NEW+FYN+AND+VEGFR2+KINASE+INHIBITORS&rft.inventor=BOVINO%2C+Clara&rft.inventor=MAGARACI%2C+Filippo&rft.inventor=ROVATI%2C+Lucio+Claudio&rft.inventor=COLACE%2C+Fabrizio&rft.inventor=MANDELLI%2C+Stefano&rft.inventor=MENNUNI%2C+Laura&rft.inventor=ARTUSI%2C+Roberto&rft.inventor=BUZZI%2C+Benedetta&rft.inventor=CASELLI%2C+Gianfranco&rft.date=2022-07-14&rft.externalDBID=A8&rft.externalDocID=WO2021116005A8